Global Anthrax Vaccines Market Growth 2023-2029

Global Anthrax Vaccines Market Growth 2023-2029

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

LPI (LP Information)' newest research report, the “Anthrax Vaccines Industry Forecast” looks at past sales and reviews total world Anthrax Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Anthrax Vaccines sales for 2023 through 2029. With Anthrax Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anthrax Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Anthrax Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anthrax Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anthrax Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anthrax Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anthrax Vaccines.

The global Anthrax Vaccines market size is projected to grow from US$ 640.8 million in 2022 to US$ 1089.9 million in 2029; it is expected to grow at a CAGR of 1089.9 from 2023 to 2029.

Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.

North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.

In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.

This report presents a comprehensive overview, market shares, and growth opportunities of Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Live Vaccines

Cell free PA Vaccines

Segmentation by application

Human Use

Animal Use

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Emergent BioSolutions

Merial

Merck

Zoetis

Bayer Sanidad Animal

Colorado Serum

PharmAthene

Tiankang

Biogénesis-Bago

CAVAC

Rosenbusch

Agrovet

Vecol

CVCRI

IVPM

Prondil

CDV

Indian Immunologicals

Botswana Vaccine Institute

Ceva Santé Animale

Intervac

JOVAC

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anthrax Vaccines market?

What factors are driving Anthrax Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anthrax Vaccines market opportunities vary by end market size?

How does Anthrax Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.